Pulmonology Symposium

Continuing Education Statements of Credit Learn More

The National Medical Association is accredited by the Accreditation Council for Continuing Medical Education to...

Acknowledgement of Support and Disclosure Learn More

This educational activity was made possible in part by educational grants from the following: Baxter Healthcare Corporation, CSL Behring LLC and Grifols

Background Needs Assessment Learn More

Alpha-one-antitrypsin deficiency predisposes to lung disease (eg: emphysema and bronchiectasis), liver disease...

References & Suggested Readings Learn More

Tomashefski JF Jr, et al. The Bronchopulmonary pathology of alpha-one-antitrypsin AAT deficiency...


Pulmonology Symposium

This symposium will discuss Alpha-1-antitrypsin deficiency (AAT) and Pulmonary hypertension. AAT is an underrecognized genetic condition affecting approximately 1 in 2000 to 1 in 5000 individuals and predisposes to liver disease and early onset emphysema. Pulmonary hypertension is pathophysiological and hemodynamic state associated with several clinical conditions that can lead to progressive right ventricular failure and death.

Publish Date: 08/24/2012
Number of Videos: 2